ALBHF

Alibaba Health Schedules Board Meeting to Review Interim Results

Alibaba Health Information Technology (HK:0241) has released an update.

Alibaba Health Information Technology Limited has announced an upcoming board meeting scheduled for November 13, 2024, to discuss and approve the company’s unaudited interim results for the six months ending September 30, 2024. The meeting will also consider the recommendation of an interim dividend. This announcement is of particular interest to investors keeping an eye on Alibaba Health’s financial performance and potential dividend payouts.

For further insights into HK:0241 stock, check out TipRanks’ Stock Analysis page.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.